BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 728880)

  • 1. Periurethral prostatic duct carcinoma: clinical features and treatment results.
    Kopelson G; Harisiadis L; Romas NA; Veenema RJ; Tannenbaum M
    Cancer; 1978 Dec; 42(6):2894-902. PubMed ID: 728880
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of transitional cell carcinoma of the prostate.
    Shenasky JH; Gillenwater JY
    J Urol; 1972 Sep; 108(3):462-5. PubMed ID: 5052255
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic, clinical and therapeutic aspects of primary transitional cell carcinoma of the prostate].
    Mottola A; Di Cello V; Lunghi F; Saltutti C; Natali A; Bianchi S
    Minerva Urol Nefrol; 1991; 43(1):37-9. PubMed ID: 2057864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary transitional cell carcinoma of the prostate.
    Greene LF; Mulcahy JJ; Warren MM; Dockerty MB
    J Urol; 1973 Aug; 110(2):235-7. PubMed ID: 4722621
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary transitional cell carcinoma of the prostate.
    Greene LF; O'Dea MJ; Dockerty MB
    J Urol; 1976 Dec; 116(6):761-3. PubMed ID: 1003646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary primary duct adenocarcinoma of the prostate.
    Dube VE; Joyce GT; Kennedy E
    J Urol; 1972 May; 107(5):825-6. PubMed ID: 5022552
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical aspects of prostatic carcinoma.
    Foo KT; Tan EC; Tung KH; Lee YS
    Singapore Med J; 1982 Oct; 23(5):269-72. PubMed ID: 7157007
    [No Abstract]   [Full Text] [Related]  

  • 8. The significance and management of transitional cell carcinoma of the prostate.
    Montie JE; Wood DP; Mendendorp SV; Levin HS; Pontes JE
    Semin Urol; 1990 Nov; 8(4):262-8. PubMed ID: 2284532
    [No Abstract]   [Full Text] [Related]  

  • 9. The conundrum of prostatic urethral involvement.
    Ingimarsson JP; Seigne JD
    Urol Clin North Am; 2013 May; 40(2):249-59. PubMed ID: 23540782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophysectomy for reactivated disseminated prostatic carcinoma.
    Schoonees R; Bourke RS; Reynoso G; Murphy GP; Sćhalch DS
    S Afr Med J; 1972 Sep; 46(36):1278-85. PubMed ID: 4118726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unusual features in a patient with both transitional cell carcinoma and adenocarcinoma of the prostate].
    Savion M; Mor C
    Harefuah; 1985 Feb; 108(4):189-90. PubMed ID: 4007667
    [No Abstract]   [Full Text] [Related]  

  • 12. Transrectal ultrasound appearance of transitional cell carcinoma involving the prostate.
    Terris MK; Villers A; Freiha FS
    J Urol; 1990 May; 143(5):952-6. PubMed ID: 2184257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 15. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic duct carcinoma: exfoliative cytology.
    Ramzy I; Larson V
    Acta Cytol; 1977; 21(3):417-20. PubMed ID: 268122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
    Lerner SP; Shen S
    Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.
    Huggins C; Hodges CV
    CA Cancer J Clin; 1972; 22(4):232-40. PubMed ID: 4625049
    [No Abstract]   [Full Text] [Related]  

  • 19. Transitional cell carcinoma of the prostate.
    Matzkin H; Soloway MS; Hardeman S
    J Urol; 1991 Nov; 146(5):1207-12. PubMed ID: 1942262
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-morphological characteristics of transitional cell carcinoma of the prostate].
    Samsonov VA
    Vopr Onkol; 1985; 31(4):66-70. PubMed ID: 4002672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.